Harvard
Wyss Institute, Brigham and Women's Hospital Launch Diagnostic Technology Accelerator
Through the accelerator, Brigham and Women's investigators will identify diagnostic challenges that will be matched with technologies created by Wyss engineers.
FDA Grants Emergency Use Authorizations for SARS-CoV-2 Tests From Harvard, NowDiagnostics
Harvard's RT-PCR-based test can be used with self-collected nasal samples, while NowDiagnostics' immunoassay can be used with fingerstick blood samples.
The group's printable biosensor plugs into a computer or smartphone and uses receptor ACE2 as well saliva or a nasal swab to detect SARS-CoV-2.
GBS Developing Organic Thin-Film Transistor Tech to Detect SARS-CoV-2 Antibodies, Monitor Glucose
Premium
GBS said it expects that later this year it will launch a multiplex assay, which it is developing with the Wyss Institute, to detect antibodies against SARS-CoV-2.
Harvard Licenses Nasal Swab Collection Tech to Rhinostics
The technology was developed for use in SARS-CoV-2 and other infectious disease testing by Rhinostics' cofounders at Harvard's Wyss Institute.